Compare SCLX & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | TGE |
|---|---|---|
| Founded | 2011 | 2023 |
| Country | United States | France |
| Employees | N/A | 166 |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 46.3M |
| IPO Year | 2020 | N/A |
| Metric | SCLX | TGE |
|---|---|---|
| Price | $5.57 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 33.3K |
| Earning Date | 04-10-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | N/A |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $2.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $0.78 |
| 52 Week High | $34.27 | $4.40 |
| Indicator | SCLX | TGE |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 54.64 |
| Support Level | $5.48 | $0.91 |
| Resistance Level | $7.77 | $1.01 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 11.55 | 55.33 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.